BlackRock »

Intra Cellular Therapies shares owned by BlackRock

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by BlackRock

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.2B 8.8M 131.92
2024-12-31 $511M 6.1M 83.52
2024-09-30 $455M 6.2M 73.17

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Netflix (NFLX)

View all positions for BlackRock

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies